Company Overview and News

Add 532331
to your dashboard

Headline News

Ajanta Pharma Limited - Shareholders meeting

2017-10-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Interim Results

2017-08-17 londonstockexchange
17 August 2017 - India Capital Growth Fund ("ICGF" or "the Company"), the AIM quoted investment company established to take advantage of long term investment opportunities in companies based in India, today reports results for the six months ended 30 June 2017.

Ajanta Pharma Q1 net profit falls 21% to Rs 95 cr

2017-08-09 thehindubusinessline
Ajanta Pharma today reported a 20.71 per cent decline in consolidated net profit to Rs 94.79 crore for the first quarter ended June 30, mainly due to de- stocking in trade channels ahead of GST implementation.

Will Tata Motors, Eicher results drive market?

2017-08-08 thehindubusinessline
Over one hundred companies will declare their April-June quarter results on Wednesday. These include 3M, Ajanta Pharma, Aurobindo Pharma, AU Small Finance Bank, Balmer Lawrie, City Union Bank, Eicher Motors, GMDC, Greenlam Industries, GTL Infra, Inox Wind, Jai Corp, Jindal Stainless, Max Fin, Nalco, NHPC, NMDC, PTC India Fin, P&S Bank, Sanghi Movers, Tata Motors, Tube Investments, Unichem Laboratories, VA Tech Wabag, Wheels India, Wonderla and West Coast Paper Mills.

Half-year Report

2017-08-03 londonstockexchange
This report contains terminology that may be unfamiliar to some readers.  The Glossary gives definitions for frequently used terms.

Ajanta Pharma Limited - Trading Window


Ajanta Pharma Limited - Results


Ajanta Pharma set to give a major push to its US business in FY18

2017-07-19 moneycontrol
Undeterred by pricing pressures and competition in the world’s largest market for generic drugs, Ajanta Pharma plans to rapidly scale up its US business.

Indian stocks head for third-straight record, led by energy

2017-07-12 themalaymailonline
The Bombay Stock Exchange (BSE) logo is seen at the BSE building in Mumbai January 25, 2017. Driven by the energy sector, Indian shares head for third day of record-breaking highs. — Reuters picMUMBAI, July 12 — India’s main stock indexes headed for a third day of record highs, paced by a rally in energy shares.

Promoter firm reduces stake in Ajanta Pharma

2017-07-11 thehindubusinessline
Shares of Ajanta Pharma will remain in focus, as a promoter group firm cut its stake in the company. According to BSE bulk deal data, Ganga Exports, a promoter group firm, sold 24.85 lakh shares at an average price of ₹1,500.11. While SBI Mutual Fund bought 13.57 lakh shares, identity of the other buyers was not known. Ganga Exports is represented by Yogesh Agrawal, Rajesh Agrawal, Ravi Agrawal and Aayush Agrawal — promoters of Ajanta Pharma.

Ajanta Pharma Limited - Press Release


GST rollout to hit earnings of pharma cos#39; domestic formulation biz in first half of FY18

2017-07-07 moneycontrol
Indian drug makers’ domestic formulation businesses could be under strain, impacting their overall profits in the first half of this financial year, owing to the supply chain disruption caused by the roll out of Goods and Service Tax (GST).

SEBI proposes to ease FPI entry norms to dodge P-Note route

2017-06-29 indiainfoline
Market regulator, Securities and Exchange Board of India (SEBI) has taken further steps to attract foreign investors to directly invest in the Indian market, rather than taking the help of Participatory Notes (P-notes).

Ajanta Pharma Limited - Updates


Ajanta Pharma Limited - Updates


Market Live: Sensex, Nifty open at fresh record high; Hindalco up 3%

2017-05-11 moneycontrol
9:45 am Good profit margin and high dividend payout: Through a Moneycontrol study, we came across 13 companies from the BSE universe which reported net profit margins in excess of 20 percent in each of the last three financial years (FY15, FY16, and FY17).

Ajanta Pharma standalone net profit declines 21.76% in the March 2017 quarter

2017-05-03 indiainfoline
For the full year,net profit rose 18.45% to Rs 499.81 crore in the year ended March 2017 as against Rs 421.95 crore during the previous year ended March 2016. Sales rose 13.06% to Rs 1753.68 crore in the year ended March 2017 as against Rs 1551.10 crore during the previous year ended March 2016.

Ajanta Pharma Q4 net profit rises 4.64% to Rs 114 crore

2017-05-03 livemint
Ajanta Pharma had posted a net profit of Rs 108.96 crore for the March quarter of fiscal 2016